Podcasts

OUTSPOKEN ONCOLOGY

Episode 60: Drug Shortages, Supply Chain, and Pharmacies During COVID-19

05/03/2022

Niesha Griffith, RPh, MS, FASHP, and Michael Ganio, PharmD, MS, BCPS, FASHP, provide varying perspectives on the potential of drug shortages (eg, pain medications, cancer therapies, and hydroxychloroquine) emerging during the COVID-19...

Niesha Griffith, RPh, MS, FASHP,...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 59: Economic Fallout of COVID-19 With Cam Harvey

05/03/2022

Cam Harvey, PhD, professor of finance, Duke University, compares the COVID-19 pandemic to the likes of the Spanish Flu and SARS in terms of "systemic risk," breaks down the finances of the recently enacted CARES Act, floats the idea of a...

Cam Harvey, PhD, professor of...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 58: The COVID-19 War Wages On With Emily Landon

05/03/2022

Emily Landon, MD, returns to share valuable information on COVID-19 testing, ethical dilemmas regarding treatment decisions, proper N95 mask reuse and disposal, potential of durable immunity to the virus, and more.

Emily Landon, MD, returns to...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 57: The PPE Debacle During COVID-19 With Priya Sampathkumar

05/03/2022

Priya Sampathkumar, MD, breaks down truths and misconceptions of which types of individuals should wear masks in public, when N95 masks are truly needed and reasons for the potential shortage, and more.

Priya Sampathkumar, MD, breaks...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 56: Cancer Center Preparedness for the COVID-19 Pandemic

05/03/2022

Rafael Fonseca, MD, discusses the steps that large cancer centers should take to protect their patients as well as staff from COVID-19 infection, specific measures that Mayo Clinic has taken for developing in-house testing, and more.

Rafael Fonseca, MD, discusses...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Bonus Episode: Update on the Status of the COVID-19 Pandemic

05/03/2022

Chadi welcomes back Emily Landon, MD, to provide updates on issues of state-funded COVID-19 testing and laboratory resources, the importance of social distancing and isolation to limit the strain on local health systems, and more.

Chadi welcomes back Emily...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 55: Patient Advocacy and Engagement in Regulatory Affairs With David Mitchell

05/03/2022

David Mitchell, president and founder of Patients for Affordable Drugs, discusses the need for an entity to recommend costs for novel therapies to payers, pieces of legislation that address drug patent "abuse" on the part of manufacturers,...

David Mitchell, president and...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Bonus Episode: COVID-19 With Emily Landon—A True Pandemic

05/03/2022

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, breaks down current exposure risk and mortality rates of COVID-19, preventative steps to avoid exposure, and promising therapies on the...

Emily Landon, MD, executive...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 54: Physician Debate on the US Payer System With Rafael Fonseca and Saurabh Jha

05/03/2022

Rafael Fonseca, MD, and Saurabh Jha, MD, debate the benefits and disadvantages of a third-party vs single payer system and whether Medicare has been a successful program for qualifying patients.

Rafael Fonseca, MD, and Saurabh...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 53: Truths and Myths of 340B With Sayeh Nikpay

05/03/2022

Sayeh Nikpay, PhD, MPH, Vanderbilt University School of Medicine, explains the origins of 340B, how safety net clinics as well as large hospitals became participants in the program, and the possibility of getting rid of the program...

Sayeh Nikpay, PhD, MPH,...

05/03/2022

Journal of Clinical Pathways